Transgene Biotek Share Price
19 Aug, 2026 3:29 PM (IST)
Transgene Biotek Performance
- Today's Low
- ₹3
- Today's High
- ₹3
- 52 Week Low
- ₹2
- 52 Week High
- ₹5
- Open Price₹3
- Previous Close₹3
- Volume38,540
- 50 DMA₹3.00
- 100 DMA₹3.00
- 200 DMA₹3.20
Transgene Biotek Chart
Investment Returns
- Over 1 Month -10.89%
- Over 3 Month -14.01%
- Over 6 Month + 3.05%
- Over 1 Year -39.05%
Smart Investing Starts Here Start SIP with Transgene Biotek for Steady Growth!
Transgene Biotek Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -12.7
- PEG Ratio
- 0.6
- Market Cap Cr
- 21
- P/B Ratio
- 2.4
- Average True Range
- 0.3
- EPS
- -0.2
- Dividend Yield
- 0
- MACD Signal
- -
- RSI
- 40.43
- MFI
- 48.79
Latest Stock News Updates
Newspaper Publication
- BSE India
- 1 week 1 day ago
Unaudited Financial Results for the quarter ended 30th June 2026.
- BSE India
- 1 week 5 days ago
Sub: Outcome of the Meeting of the Board of Directors held on August 07, 2026. This has reference to our letter dated 22nd July 2026, Intimating the meeting of the Board of Directors of the Company. At a meeting of the Board of Directors of the company held on 07th August 2026 the following decisions have been taken: 1) The Board considered and approved the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 30th June 2026. 2) The Board considered and approved the Limited Review Report (Standalone & Consolidated) of the Company for the quarter ended 30th June 2026. 3) The Board considered and approved the extension of the date of Annual General Meeting (AGM) of the Company for the financial year 2025-26, subject to obtaining the necessary approval from the Registrar of Companies, wherever applicable.
- BSE India
- 1 week 5 days ago
Transgene Biotek Financials
Transgene Biotek Technicals
EMA & SMA
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹2.90
- 50 Day
- ₹3.00
- 100 Day
- ₹3.00
- 200 Day
- ₹3.20
Resistance and Support
- R3 3.10
- R2 3.00
- R1 2.90
- S1 2.60
- S2 2.60
- S3 2.40
Transgene Biotek Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-08-07 | Quarterly Results & Others | |
| 2026-05-29 | Audited Results | |
| 2026-02-13 | Quarterly Results | |
| 2025-11-14 | Quarterly Results | |
| 2025-08-07 | Quarterly Results |
About Transgene Biotek
Transgene Biotek is an Indian public biotech firm, established in 1990, focused on R&D for vaccines, oncology, biogenerics, and novel drug delivery (oral/nasal proteins/peptides) for unmet needs, exporting to various global markets and developing treatments for cancer, auto-immune issues, etc View More- NSE Symbol
- TRABI
- BSE Symbol
- 526139
- ISIN
- INE773D01018
Similar Stocks to Transgene Biotek
Popular Stocks
Transgene Biotek FAQs
Transgene Biotek share price is ₹2 As on 19 August, 2026 | 22:36
The Market Cap of Transgene Biotek is ₹20.5 Cr As on 19 August, 2026 | 22:36
The P/E ratio of Transgene Biotek is -12.7 As on 19 August, 2026 | 22:36
The PB ratio of Transgene Biotek is 2.4 As on 19 August, 2026 | 22:36
The 52 week High & Low of Transgene Biotek is ₹4.7/₹1.8 respectively As on 19 August, 2026 | 22:36
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.